NCT07040033

Brief Summary

cardiac rehabilitation includes topics such as smoking cessation recommendations, weight management, nutritional counseling, blood pressure management, physical activity counseling, diabetes management, psychosocial management in order to reduce CV risk factors, reduce morbidity and mortality rates, and improve the individual's quality of life . In CV diseases, it has been shown that education and motivation provided under the leadership of nurses are effective in preventing the disease. This success stems from the nurse's holistic approach to the individual and determination of individual-specific needs. It is important for nurses, who are seen as a source of support by the society, to identify empowerment in CV patients and to support patients for independent living. kigai is a well-known term in Japan. This term is sometimes translated as 'purpose in life' and sometimes it can be defined as 'joy of life'. When Ikigai is mentioned, both the source of Ikigai within the individual or the object of Ikigai, and the psychological/emotional state (Ikigai-kan) in which Ikigai is felt come to mind. Accordingly, 'Ikigai' can be defined as the source or object of the purpose/joy of life, and 'Ikigai-kan' as the psychological/emotional state in which these are felt. In addition to the ways in which individuals with cardiovascular disease manage their disease, take precautions against risk factors, and perform strengthening exercises, determining the patients' current state of mind is also an important element. In this sense, physicians and nurses in the clinic take these elements into consideration when planning the care to be provided to patients. No study has been found in the literature to date that evaluates the relationship between CAH strengthening and Ikigia. Based on this information, this study aims to examine the relationship between CAH strengthening and Ikigai. It is expected that the research results will guide physicians and nurses who care for individuals with CAH in planning the care to be provided to patients and contribute to the literature.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 11, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

June 26, 2025

Completed
19 days until next milestone

Study Start

First participant enrolled

July 15, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 25, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

September 3, 2025

Status Verified

June 1, 2025

Enrollment Period

1 month

First QC Date

June 11, 2025

Last Update Submit

August 26, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Title: Determining the relationship between empowerment and ikigai levels in individuals diagnosed with Chronic Lung Disease (CLD)

    Description: The relationship between participants' empowerment levels and their ikigai levels will be evaluated using validated and reliable scales through descriptive statistics and correlation analysis.

    2 months from the start of the study

Secondary Outcomes (2)

  • Relationship between sociodemographic characteristics and empowerment and ikigai levels

    2 months from the start of the study

  • Title: Relationship between quality of life and ikigai levels

    2 months from the start of the study

Interventions

There will be no intervention

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

300

You may qualify if:

  • Clinical diagnosis of Coronary Artery Disease
  • Must be in a stable phase of the disease
  • Speak and understand Turkish
  • Must be 18 years of age or older

You may not qualify if:

  • Diagnosed with a mental illness or communication disorder
  • Presence of significant hearing or vision disorders
  • Intubated Coronary Artery Disease patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kutahya Health Sciences University

Merkez, Kütahya, 43200, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Personal Satisfaction

Condition Hierarchy (Ancestors)

Behavior

Central Study Contacts

Mehmet A Astarcıoğlu, Professor

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 11, 2025

First Posted

June 26, 2025

Study Start

July 15, 2025

Primary Completion

August 25, 2025

Study Completion

October 1, 2025

Last Updated

September 3, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations